ASTEX PHARMACEUTICALS, INC Operating Expenses
ASTEX PHARMACEUTICALS, INC reported Operating Expenses of $23.73 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2013-08-09
- ASTEX PHARMACEUTICALS, INC operating expenses for the quarter ending 2013-06-30 was $23.73M, a 16.97% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC operating expenses for the quarter ending 2013-03-31 was $23.91M, a 16.25% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC operating expenses for the quarter ending 2012-12-31 was $22.78M, a 3.81% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC operating expenses for the quarter ending 2012-09-30 was $26.59M, a 32.09% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC operating expenses for fiscal 2012 was $90.21M, a 39.86% increase from fiscal 2011.
- ASTEX PHARMACEUTICALS, INC operating expenses for fiscal 2011 was $64.50M, a 73.93% increase from fiscal 2010.
- ASTEX PHARMACEUTICALS, INC operating expenses for fiscal 2010 was $37.09M, a 2.63% decline from fiscal 2009.
- ASTEX PHARMACEUTICALS, INC operating expenses for fiscal 2009 was $38.09M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2013-06-30 | $23.73M 10-Q · filed 2013-08-09 | $47.63M 10-Q · filed 2013-08-09 | $70.41M derived: sum of 3 quarters · filed 2013-08-09 | $96.99M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $23.91M 10-Q · filed 2013-05-10 | $46.68M derived: sum of 2 quarters · filed 2013-05-10 | $73.27M derived: sum of 3 quarters · filed 2013-05-10 | $93.55M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $22.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $49.36M derived: sum of 2 quarters · filed 2013-03-18 | $69.65M derived: sum of 3 quarters · filed 2013-08-09 | $90.21M 10-K · filed 2013-03-18 |
| 2012-09-30 | $26.59M 10-Q · filed 2012-11-09 | $46.87M derived: sum of 2 quarters · filed 2013-08-09 | $67.43M 10-Q · filed 2012-11-09 | $89.37M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $20.29M 10-Q · filed 2013-08-09 | $40.85M 10-Q · filed 2013-08-09 | $62.79M derived: sum of 3 quarters · filed 2013-08-09 | $82.92M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $20.56M 10-Q · filed 2013-05-10 | $42.50M derived: sum of 2 quarters · filed 2013-05-10 | $62.63M derived: sum of 3 quarters · filed 2013-05-10 | $73.45M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $21.94M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $42.07M derived: sum of 2 quarters · filed 2013-03-18 | $52.89M derived: sum of 3 quarters · filed 2013-03-18 | $64.50M 10-K · filed 2013-03-18 |
| 2011-09-30 | $20.13M 10-Q · filed 2012-11-09 | $30.95M derived: sum of 2 quarters · filed 2012-11-09 | $42.56M 10-Q · filed 2012-11-09 | $51.36M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $10.82M 10-Q · filed 2012-08-09 | $22.44M 10-Q · filed 2012-08-09 | $31.23M derived: sum of 3 quarters · filed 2013-03-18 | $40.75M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $11.61M 10-Q · filed 2012-05-10 | $20.41M derived: sum of 2 quarters · filed 2013-03-18 | $29.93M derived: sum of 3 quarters · filed 2013-03-18 | $38.90M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $18.31M derived: sum of 2 quarters · filed 2013-03-18 | $27.29M derived: sum of 3 quarters · filed 2013-03-18 | $37.09M 10-K · filed 2013-03-18 |
| 2010-09-30 | $9.52M 10-Q · filed 2011-11-09 | $18.49M derived: sum of 2 quarters · filed 2011-11-09 | $28.29M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $8.98M 10-Q · filed 2011-08-09 | $18.77M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $38.09M 10-K · filed 2012-03-15 |